• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[埃罗省(法国南部一省)的肾细胞癌:30年期间的结果]

[Renal cell carcinoma in the department of Hérault: Results over a 30 year period].

作者信息

Hutin M, Trétarre B, Gras C, Bessaoud F, Daurès J-P, Delbos O, Bringer J-P, Ayuso D, Thuret R, Azria D, Serre I, Brel D, Reis Borges R, Iborra F, Rébillard X

机构信息

Service d'urologie, Clinique Beau Soleil, 119, avenue de Lodève, 34070 Montpellier, France; Service d'urologie, Centre Hospitalier Intercommunal du Bassin de Thau, boulevard Camille Blanc, 34200 Sète, France.

Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France.

出版信息

Prog Urol. 2021 Mar;31(3):175-182. doi: 10.1016/j.purol.2020.10.001. Epub 2020 Nov 5.

DOI:10.1016/j.purol.2020.10.001
PMID:33160850
Abstract

OBJECTIVE

The objective of the study was to determine the specificities of renal cell carcinoma (RCC) in the department of Herault using the Herault Tumor Registry over 30 years.

METHODS

Data of this study were obtained from the Herault cancer database. We analysed the evolution of RCC from 1987 to 2016, including the incidence, mortality, cancer pathology and staging at the moment of diagnosis. We compared our results with national and international data.

RESULTS

We identified 3769 newly diagnosed RCC: 2628 in men (69,7%) and 1141 in women (30,3%). In 2016, RCC was the 8th most frequent cancer, both genders combined, the 7th most frequent cancer in men and the 11th in women. New cases of RCC increased by 4.2 in men and 3.3 in women over the study period. The number of localised forms increased by 9% over 20 years. In 2016, the probability of having a RCC before the age of 75 was of 2.11% for a man and of 0.62% for a woman.

CONCLUSION

Over 30 years, the incidence rate of RCC increased in the department of Herault; however, mortality decreased over the same period. This analytical data should be improved by the development of the Registry of Herault Specialised in Onco-Urology (RHESOU).

LEVEL OF EVIDENCE

摘要

目的

本研究的目的是利用埃罗省肿瘤登记处的数据,确定30年来埃罗省肾细胞癌(RCC)的特异性。

方法

本研究数据来自埃罗省癌症数据库。我们分析了1987年至2016年肾细胞癌的演变情况,包括发病率、死亡率、癌症病理及诊断时的分期。我们将研究结果与国内和国际数据进行了比较。

结果

我们共识别出3769例新诊断的肾细胞癌患者:男性2628例(69.7%),女性1141例(30.3%)。2016年,肾细胞癌是男女合计第8大常见癌症,男性中第7大常见癌症,女性中第11大常见癌症。在研究期间,男性肾细胞癌新发病例增加了4.2例,女性增加了3.3例。20年间,局限性病例数量增加了9%。2016年,75岁前患肾细胞癌的概率男性为2.11%,女性为0.62%。

结论

30年来,埃罗省肾细胞癌发病率上升;然而,同期死亡率下降。埃罗省肿瘤泌尿专科登记处(RHESOU)的发展应能改善这些分析数据。

证据水平

3级。

相似文献

1
[Renal cell carcinoma in the department of Hérault: Results over a 30 year period].[埃罗省(法国南部一省)的肾细胞癌:30年期间的结果]
Prog Urol. 2021 Mar;31(3):175-182. doi: 10.1016/j.purol.2020.10.001. Epub 2020 Nov 5.
2
[Bladder tumors in the Hérault department: Results of the Hérault tumor registry registration from1987 to 2019].
Prog Urol. 2023 Dec;33(15-16):974-982. doi: 10.1016/j.purol.2023.08.015. Epub 2023 Aug 28.
3
[RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience].[埃罗省肿瘤泌尿专科登记处(RHESOU):法国首个肿瘤泌尿专科登记处。一年经验]
Prog Urol. 2020 Dec;30(16):1038-1044. doi: 10.1016/j.purol.2020.09.015. Epub 2020 Oct 1.
4
[Cancers of the external genital organs of male in Hérault: Results from the Hérault tumor register (RTH) over a period of 30 years (1987-2016)].埃罗省男性外生殖器癌症:埃罗省肿瘤登记处(RTH)30年(1987 - 2016年)的结果
Prog Urol. 2021 Apr;31(5):282-292. doi: 10.1016/j.purol.2020.08.054. Epub 2021 Feb 13.
5
Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?透析和移植患者的原肾发生的肾细胞癌(RCC):它们是不同的实体吗?
BJU Int. 2012 Dec;110(11 Pt B):E570-3. doi: 10.1111/j.1464-410X.2012.11273.x. Epub 2012 Jun 22.
6
Kidney cancer in Sweden: a decrease in incidence and tumour stage, 1979 - 2001.瑞典的肾癌:1979 - 2001年发病率及肿瘤分期的下降情况
Scand J Urol. 2013 Aug;47(4):302-10. doi: 10.3109/00365599.2012.732608. Epub 2012 Nov 9.
7
Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.同期双侧肾癌的风险因素:监测、流行病学和最终结果分析。
Cancer. 2019 Jan 15;125(2):232-238. doi: 10.1002/cncr.31689. Epub 2018 Dec 18.
8
Epidemiology, clinical staging, and presentation of renal cell carcinoma.肾细胞癌的流行病学、临床分期及表现
Urol Clin North Am. 2008 Nov;35(4):581-92; vi. doi: 10.1016/j.ucl.2008.07.005.
9
Characterizing changes in kidney and renal pelvis cancer incidence from 1998 to 2006 in the United States.描述 1998 年至 2006 年美国肾脏和肾盂癌发病率的变化。
Int Urol Nephrol. 2011 Jun;43(2):359-63. doi: 10.1007/s11255-010-9827-3. Epub 2010 Sep 5.
10
The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.美国肾腺癌发病率长期迅速上升,尤其是在较年轻人群中。
Int J Epidemiol. 2019 Dec 1;48(6):1886-1896. doi: 10.1093/ije/dyz136.

引用本文的文献

1
High-Concentration Metformin Reduces Oxidative Stress Injury and Inhibits the Growth and Migration of Clear Cell Renal Cell Carcinoma.高浓度二甲双胍可减轻氧化应激损伤并抑制肾透明细胞癌的生长和迁移。
Comput Math Methods Med. 2022 May 10;2022:1466991. doi: 10.1155/2022/1466991. eCollection 2022.